{"id":197,"date":"2021-03-05T09:06:59","date_gmt":"2021-03-05T09:06:59","guid":{"rendered":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/?post_type=press-release&#038;p=197"},"modified":"2024-05-07T18:53:31","modified_gmt":"2024-05-07T18:53:31","slug":"ona-therapeutics-appoints-mark-throsby-to-its-board-of-directors","status":"publish","type":"press-release","link":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-mark-throsby-to-its-board-of-directors\/","title":{"rendered":"ONA Therapeutics appoints Mark Throsby to its Board of Directors"},"content":{"rendered":"<p><strong>Barcelona, Spain, March 5th, 2021<\/strong>: Ona Therapeutics, a company focused on the discovery and development of therapeutic biologics to treat metastatic cancer, announces today that it has appointed Dr. Mark Throsby as independent board member of its Board of Directors. Dr. Throsby is a proven senior executive with more than 20 years of experience in the pharma &amp; biotech industry and has led multiple drug discovery programs from conception to the clinic.<\/p>\n<p><a href=\"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-content\/uploads\/2024\/05\/2021_03_05-Mark-Throsby-PR_final.pdf\" target=\"_blank\" rel=\"noreferrer noopener\" data-type=\"URL\" data-id=\"https:\/\/ona-therapeutics.com\/wp-content\/uploads\/2021\/03\/2021_03_05-Mark-Throsby-PR_final.pdf\">See more details in the press release<\/a><\/p>\n","protected":false},"template":"","class_list":["post-197","press-release","type-press-release","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ona Therapeutics | ONA Therapeutics appoints Mark Throsby to its Board of Directors<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-mark-throsby-to-its-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ona Therapeutics | ONA Therapeutics appoints Mark Throsby to its Board of Directors\" \/>\n<meta property=\"og:description\" content=\"Barcelona, Spain, March 5th, 2021: Ona Therapeutics, a company focused on the discovery and development of therapeutic biologics to treat metastatic cancer, announces today that it has appointed Dr. Mark Throsby as independent board member of its Board of Directors. Dr. Throsby is a proven senior executive with more than 20 years of experience in [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-mark-throsby-to-its-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Ona Therapeutics\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-07T18:53:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-content\/uploads\/2024\/05\/logo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"968\" \/>\n\t<meta property=\"og:image:height\" content=\"440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@onatherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/ona-therapeutics-appoints-mark-throsby-to-its-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/ona-therapeutics-appoints-mark-throsby-to-its-board-of-directors\\\/\",\"name\":\"Ona Therapeutics | ONA Therapeutics appoints Mark Throsby to its Board of Directors\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#website\"},\"datePublished\":\"2021-03-05T09:06:59+00:00\",\"dateModified\":\"2024-05-07T18:53:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/ona-therapeutics-appoints-mark-throsby-to-its-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/ona-therapeutics-appoints-mark-throsby-to-its-board-of-directors\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/ona-therapeutics-appoints-mark-throsby-to-its-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ONA Therapeutics appoints Mark Throsby to its Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#website\",\"url\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/\",\"name\":\"Ona Therapeutics\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#organization\",\"name\":\"Ona Therapeutics\",\"url\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/logo.png\",\"width\":968,\"height\":440,\"caption\":\"Ona Therapeutics\"},\"image\":{\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/onatherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ona-therapeutics\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ona Therapeutics | ONA Therapeutics appoints Mark Throsby to its Board of Directors","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-mark-throsby-to-its-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Ona Therapeutics | ONA Therapeutics appoints Mark Throsby to its Board of Directors","og_description":"Barcelona, Spain, March 5th, 2021: Ona Therapeutics, a company focused on the discovery and development of therapeutic biologics to treat metastatic cancer, announces today that it has appointed Dr. Mark Throsby as independent board member of its Board of Directors. Dr. Throsby is a proven senior executive with more than 20 years of experience in [&hellip;]","og_url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-mark-throsby-to-its-board-of-directors\/","og_site_name":"Ona Therapeutics","article_modified_time":"2024-05-07T18:53:31+00:00","og_image":[{"width":968,"height":440,"url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-content\/uploads\/2024\/05\/logo.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@onatherapeutics","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-mark-throsby-to-its-board-of-directors\/","url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-mark-throsby-to-its-board-of-directors\/","name":"Ona Therapeutics | ONA Therapeutics appoints Mark Throsby to its Board of Directors","isPartOf":{"@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#website"},"datePublished":"2021-03-05T09:06:59+00:00","dateModified":"2024-05-07T18:53:31+00:00","breadcrumb":{"@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-mark-throsby-to-its-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-mark-throsby-to-its-board-of-directors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-appoints-mark-throsby-to-its-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/"},{"@type":"ListItem","position":2,"name":"ONA Therapeutics appoints Mark Throsby to its Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#website","url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/","name":"Ona Therapeutics","description":"","publisher":{"@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#organization","name":"Ona Therapeutics","url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#\/schema\/logo\/image\/","url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-content\/uploads\/2024\/05\/logo.png","contentUrl":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-content\/uploads\/2024\/05\/logo.png","width":968,"height":440,"caption":"Ona Therapeutics"},"image":{"@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/onatherapeutics","https:\/\/www.linkedin.com\/company\/ona-therapeutics\/"]}]}},"_links":{"self":[{"href":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-json\/wp\/v2\/press-release\/197","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-json\/wp\/v2\/press-release"}],"about":[{"href":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-json\/wp\/v2\/types\/press-release"}],"wp:attachment":[{"href":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-json\/wp\/v2\/media?parent=197"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}